Brightsurf Science News & Current Events

September 20, 2020
Studies investigate marine heatwaves, shifting ocean currents
Two new studies from the Woods Hole Oceanographic Institution (WHOI) investigate marine heatwaves and currents at the edge of the continental shelf, which impact regional ocean circulation and marine life.

Study links higher level of exercise to 25% to 32% lower risk of all-cause mortality in people with type 2 diabetes
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, shows that having a greater exercise capacity is associated with a significantly decreased all-cause mortality risk of between 25-33% in people with type 2 diabetes (T2D).

No benefit for post-operative radiotherapy in non-small-cell lung cancer
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020.

KRAS inhibitor sotorasib appears safe, achieves durable clinical benefit in early trial
For patients with advanced solid cancers and KRAS G12C mutations, the targeted therapy sotorasib, a KRAS G12C inhibitor, resulted in manageable toxicities and durable clinical benefits, particularly in lung and colorectal cancer, in Phase I study.

When is HIIT the best exercise fit?
Determining whether high-intensity interval training (HIIT) is an appropriate form of exercise for the average person has been hotly debated for years.

PARPi olaparib for the targeted treatment of metastatic prostate cancer
Results from the PROfound phase III study open up a new treatment avenue for the more precise and effective treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed with hormonal therapy.

Study shows that rheumatoid arthritis is associated with a 23% increased risk of developing diabetes
A new study presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year, shows that rheumatoid arthritis (RA) is associated with a 23% increased risk of type 2 diabetes (T2D), and may indicate that both diseases are linked to the body's inflammatory response.

Couples can show linked behaviour in terms of risk factors to prevent type 2 diabetes
New research being presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, shows that when one half of a couple shows high levels of certain behaviours that prevent type 2 diabetes, such as good diet or exercise, that behaviour also tends to be high in the other half of the couple.

Giant spider provides promise of pain relief for irritable bowel syndrome
Molecules from the venom of one of the world's largest spiders could help University of Queensland-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

Screening UK Biobank blood samples identifies thousands of undiagnosed cases of type 2 diabetes
A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.

Revealed: Large discrepancies in accounting for the funding sources of some UK patient organisations
New analysis published in BMJ Open raises transparency concerns over funding to patient groups from big drug companies.

Study shows the major impact of diabetes on the risk of falls
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated with a 19% increased risk of falls.

Early birds vs night owls: for diabetics, an early bedtime is best
Early to bed, early to rise...while the old saying promises health, wealth and wisdom, new research confirms part of the adage holds true, as a world first study shows that people who go to bed early are more likely to be in better health and more physically active compared to night owls.

Promising phase 1 trial results: Use of sotorasib (AMG 510) in patients with solid tumors
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other renowned comprehensive cancer centers.

First new drug in years reduces recurrence in high risk HR+ early breast cancer
Lugano, Switzerland, 20 September 2020 - Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020.

Your cells look young for their age, compared to a chimp's
Many humans live to see their 80s, some even reach 100.

Male baboons with female friends live longer
Opposite-sex friendships can have non-romantic benefits. And not just for people, but for our primate cousins, too.

ESMO 2020: Breast cancer drug set to transform prostate cancer treatment
A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.